alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)

Present studies indicate that alpha-tocopherol enhances the efficacy of cisplatin as demonstrated by inoculation of Dalton's lymphoma cells incubated with either cisplatin (5 or 10 µg/ml) alone or cisplatin + alpha-tocopherol (25 or 50 µg/ml) into C3H/He mice. Tumour cells (3 x 10(6) cells/mouse) incubated with cisplatin grow slowly in syngeneic mice as indicated by the late appearance of tumour. However, mice failed to develop tumour when inoculated with tumour cells incubated with cisplatin + alpha-tocopherol. When the animals were challenged with tumour cells (3 x 10(6) cells/mouse) on the 15th day after the initial inoculation, 30-50% survived more than 60 days, with 10% tumour-free survivors being observed in some groups. Antitumour activity was higher in mice receiving lymphoma cells (3 x 10(6) cells/mouse) preincubated with cisplatin + alpha-tocopherol compared to cisplatin alone. Tumour-bearing mice receiving cisplatin in combination with different concentrations of alpha-tocopherol exhibited significantly higher (P<0.001) intratumour platinum content (123-306%) but without any change in the kidney platinum content as compared to those receiving cisplatin (5 or 10 µg/ml) alone. Enhancement of cisplatin-induced tumour growth inhibition is probably due to the modulation of tumour cell membrane permeability by alpha-tocopherol. alpha-Tocopherol might increase the influx of cisplatin into tumour cells, causing the DNA repair machinery to be less efficient due to increased efficiency of adduct formation in the DNA molecule. This effect of alpha-tocopherol can render cisplatin more effective as an antitumour agent.

Saved in:
Bibliographic Details
Main Authors: Sarna,S., Kumar,A., Bhola,R.K.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2000
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2000000800009
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2000000800009
record_format ojs
spelling oai:scielo:S0100-879X20000008000092000-07-31alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)Sarna,S.Kumar,A.Bhola,R.K. cisplatin vitamin E Dalton's lymphoma tumour growth inhibition Present studies indicate that alpha-tocopherol enhances the efficacy of cisplatin as demonstrated by inoculation of Dalton's lymphoma cells incubated with either cisplatin (5 or 10 µg/ml) alone or cisplatin + alpha-tocopherol (25 or 50 µg/ml) into C3H/He mice. Tumour cells (3 x 10(6) cells/mouse) incubated with cisplatin grow slowly in syngeneic mice as indicated by the late appearance of tumour. However, mice failed to develop tumour when inoculated with tumour cells incubated with cisplatin + alpha-tocopherol. When the animals were challenged with tumour cells (3 x 10(6) cells/mouse) on the 15th day after the initial inoculation, 30-50% survived more than 60 days, with 10% tumour-free survivors being observed in some groups. Antitumour activity was higher in mice receiving lymphoma cells (3 x 10(6) cells/mouse) preincubated with cisplatin + alpha-tocopherol compared to cisplatin alone. Tumour-bearing mice receiving cisplatin in combination with different concentrations of alpha-tocopherol exhibited significantly higher (P<0.001) intratumour platinum content (123-306%) but without any change in the kidney platinum content as compared to those receiving cisplatin (5 or 10 µg/ml) alone. Enhancement of cisplatin-induced tumour growth inhibition is probably due to the modulation of tumour cell membrane permeability by alpha-tocopherol. alpha-Tocopherol might increase the influx of cisplatin into tumour cells, causing the DNA repair machinery to be less efficient due to increased efficiency of adduct formation in the DNA molecule. This effect of alpha-tocopherol can render cisplatin more effective as an antitumour agent.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.33 n.8 20002000-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2000000800009en10.1590/S0100-879X2000000800009
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Sarna,S.
Kumar,A.
Bhola,R.K.
spellingShingle Sarna,S.
Kumar,A.
Bhola,R.K.
alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)
author_facet Sarna,S.
Kumar,A.
Bhola,R.K.
author_sort Sarna,S.
title alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)
title_short alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)
title_full alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)
title_fullStr alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)
title_full_unstemmed alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)
title_sort alpha-tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (ii)
description Present studies indicate that alpha-tocopherol enhances the efficacy of cisplatin as demonstrated by inoculation of Dalton's lymphoma cells incubated with either cisplatin (5 or 10 µg/ml) alone or cisplatin + alpha-tocopherol (25 or 50 µg/ml) into C3H/He mice. Tumour cells (3 x 10(6) cells/mouse) incubated with cisplatin grow slowly in syngeneic mice as indicated by the late appearance of tumour. However, mice failed to develop tumour when inoculated with tumour cells incubated with cisplatin + alpha-tocopherol. When the animals were challenged with tumour cells (3 x 10(6) cells/mouse) on the 15th day after the initial inoculation, 30-50% survived more than 60 days, with 10% tumour-free survivors being observed in some groups. Antitumour activity was higher in mice receiving lymphoma cells (3 x 10(6) cells/mouse) preincubated with cisplatin + alpha-tocopherol compared to cisplatin alone. Tumour-bearing mice receiving cisplatin in combination with different concentrations of alpha-tocopherol exhibited significantly higher (P<0.001) intratumour platinum content (123-306%) but without any change in the kidney platinum content as compared to those receiving cisplatin (5 or 10 µg/ml) alone. Enhancement of cisplatin-induced tumour growth inhibition is probably due to the modulation of tumour cell membrane permeability by alpha-tocopherol. alpha-Tocopherol might increase the influx of cisplatin into tumour cells, causing the DNA repair machinery to be less efficient due to increased efficiency of adduct formation in the DNA molecule. This effect of alpha-tocopherol can render cisplatin more effective as an antitumour agent.
publisher Associação Brasileira de Divulgação Científica
publishDate 2000
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2000000800009
work_keys_str_mv AT sarnas alphatocopherolenhancestumourgrowthinhibitionbycisdichlorodiammineplatinumii
AT kumara alphatocopherolenhancestumourgrowthinhibitionbycisdichlorodiammineplatinumii
AT bholark alphatocopherolenhancestumourgrowthinhibitionbycisdichlorodiammineplatinumii
_version_ 1756390972407676928